Dosage and administration
Apply a light mist to wet or dry hair then gently brush completely through the hair. No rinsing necessary.
Apply a light mist to wet or dry hair then gently brush completely through the hair. No rinsing necessary.
Rosmarinus Officinalis (Rosemary) Leaf Oil.
Topical hair detangler.
Water/Eau/Aqua, Oleth-20, Propylene Glycol, Dicetyldimonium Chloride, Styrene/Acrylamide Copolymer, Cymbopogon Nardus (Citronella) Oil, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Eucalyptus Globulus Leaf Oil, Lavandula Angustifolia (Lavender) Oil, Prunus Serotina (Wild Cherry) Bark Extract, Chamomilla Recutita (Matricaria) Extract, Salvia Officinalis (Sage) Leaf Extract, Geranium Maculatum (Geranium) Extract, Cymbopogon Schoenanthus (Lemongrass) Extract, Quercus Alba Bark Extract, Symphytum Officinale Extract, Rosa Canina Fruit Extract, Hamamelis Virginiana (Witch Hazel) Water, Aloe Barbadensis Leaf Juice, Panthenol, Hydrolyzed Soy Protein, Hydrolyzed Silk Protein, Glycolic Acid,Polysorbate 20, Imidazolidinyl Urea, Fragrance (Parfum).
Apply a light mist to wet or dry hair then gently brush completely through the hair. No rinsing necessary.
Zippity Doo's™
PEDIATRICIAN
APPROVED
LEAVE-IN DETANGLER FOR CHILDREN
daily use • repels lice
Made with a special combination of
natural ingredients
including Silk Protein, Wild Cherry Bark,
Rosemary, Tea Tree & Sage
Extracts designed to detangle,
moisturize & eliminate frizz
while repelling lice.
8.3 FL OZ (245 mL)

| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57240-2034-1 | 2019-11-27 | C162847 | 48780-1 | 9855d018-e648-cd31-e053-dbdaa90ab51a | Zippity Doo's™ LEAVE-IN DETANGLER FOR CHILDREN |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57240-2034-1 | Zippity Doos LEAVE-IN DETANGLER FOR CHILDREN | 245 mL in 1 BOTTLE | SPRAY | 245 | 2 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 57240-2034 | ZIPPITY DOOS LEAVE-IN DETANGLER FOR CHILDREN (ROSEMARY OIL) SPRAY [LAURUS ENTERPRISES, LLC] | 2 | Legacy NDC, 1 package rows | 20130410_43bf7f40-68c5-40f2-aa64-010dea841fc6.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Rosemary Oil | ACTIVE INGREDIENT | 8LGU7VM393 | 2 | |
| Rosemary Oil | ACTIVE MOIETY | 8LGU7VM393 | 2 | |
| Aloe Vera Leaf | INACTIVE INGREDIENT | ZY81Z83H0X | 2 | |
| Citronella Oil | INACTIVE INGREDIENT | QYO8Q067D0 | 2 | |
| Cymbopogon Schoenanthus Top | INACTIVE INGREDIENT | 9SJI1LW39W | 2 | |
| Dicetyldimonium Chloride | INACTIVE INGREDIENT | 6F4SX2007N | 2 | |
| Eucalyptus Oil | INACTIVE INGREDIENT | 2R04ONI662 | 2 | |
| Geranium Maculatum Root | INACTIVE INGREDIENT | 93IXI5B6OJ | 2 | |
| Glycolic Acid | INACTIVE INGREDIENT | 0WT12SX38S | 2 | |
| Hamamelis Virginiana Top | INACTIVE INGREDIENT | UDA30A2JJY | 2 | |
| Imidurea | INACTIVE INGREDIENT | M629807ATL | 2 | |
| Lavender Oil | INACTIVE INGREDIENT | ZBP1YXW0H8 | 2 | |
| Matricaria Recutita | INACTIVE INGREDIENT | G0R4UBI2ZZ | 2 | |
| Oleth-20 | INACTIVE INGREDIENT | YTH167I2AG | 2 | |
| Panthenol | INACTIVE INGREDIENT | WV9CM0O67Z | 2 | |
| Polysorbate 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 2 | |
| Propylene Glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 2 | |
| Prunus Serotina Bark | INACTIVE INGREDIENT | 5D48E975HA | 2 | |
| Quercus Alba Bark | INACTIVE INGREDIENT | 93LP7Y8EGT | 2 | |
| Rosa Canina Fruit | INACTIVE INGREDIENT | 3TNW8D08V3 | 2 | |
| Sage | INACTIVE INGREDIENT | 065C5D077J | 2 | |
| Tea Tree Oil | INACTIVE INGREDIENT | VIF565UC2G | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 57240-2034 | 57240-2034-1 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, DELAYED RELEASE / ORAL | 36 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / OPHTHALMIC | 0.6 %w/v | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / VAGINAL | 6.4 %w/w | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SUSPENSION / AURICULAR (OTIC) | 0.1 %w/v | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SHAMPOO / TOPICAL | 8 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / TOPICAL | 4522 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | TAMPON / VAGINAL | 64.8 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / RESPIRATORY (INHALATION) | 25 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM, SOLUBLE / BUCCAL | 5 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | CREAM / TOPICAL | 108 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | GEL / TOPICAL | 5 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / INTRAMUSCULAR | 7459 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, METERED / RECTAL | NA | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUPPOSITORY / VAGINAL | 252 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | AEROSOL, FOAM / TOPICAL | 3.7 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / AURICULAR (OTIC) | 56.55 %w/v | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SHAMPOO / TOPICAL | 8 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / TOPICAL | 5.28 %w/v | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / SUBCUTANEOUS | 1.4 %w/v | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION / INTRAVENOUS | 30 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / RECTAL | 3315 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SPONGE / TOPICAL | 40 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION, CONCENTRATE / INTRAVENOUS | 50.33 %w/v | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | AEROSOL, FOAM / VAGINAL | 3 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / ORAL | 29008 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SOLUTION / TOPICAL | 15 %w/w | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | CAPSULE / ORAL | 563 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAVENOUS | 4000 mg | ||
| Imidurea | IMIDUREA | M629807ATL | LOTION / TOPICAL | 228 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | DROPS / ORAL | 200 mg/1ml | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 63.4 %w/v | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | EMULSION / TOPICAL | 8 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY / NASAL | 5 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION / SUBCUTANEOUS | NA | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / DENTAL | NA | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / VAGINAL | 750 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / RESPIRATORY (INHALATION) | 10 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAMUSCULAR | 4000 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | CLOTH / TOPICAL | NA | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE / ORAL | 1072 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | NA | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / DENTAL | 2 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / INTRAVENOUS | 5 %w/v | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / RECTAL | 90400 mg | ||
| Imidurea | IMIDUREA | M629807ATL | SHAMPOO / TOPICAL | 60 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL / TOPICAL | 19.2 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM / BUCCAL | 1.48 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET / ORAL | 64 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / RECTAL | 1214 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SPRAY, METERED / NASAL | 40 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SUSPENSION / OPHTHALMIC | 0.05 %w/v | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | EMULSION / TOPICAL | 2 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / OPHTHALMIC | 0.44 %w/w | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | TABLET / ORAL | 17 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 19 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / ORAL | 27120 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / RECTAL | 27 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SOAP / TOPICAL | 0.02 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 685a3436-9940-4254-b133-295d0d37d600 | 43bf7f40-68c5-40f2-aa64-010dea841fc6 | 2013-04-04 | Warnings | 685a3436-9940-4254-b133-295d0d37d600 43bf7f40-68c5-40f2-aa64-010dea841fc6 |
Adverse event summaries are temporarily unavailable. Other product information remains available.